Karuna Therapeutics' top-experimental schizophrenia drug significantly reduced symptoms in a late-stage trial but there were concerns that it could cause hypertension in patients.
Share:
More In Science
Google Unveils Health Updates at ‘The Check Up’ Health Event
Google Unveils Health Updates at ‘The Check Up’ Health Event
Nor’easter Hits the Northeast
Nor’easter Hits the Northeast
Neurologist Says Diet and Mental Exercise Can Help Prevent Alzheimer's
Dr. Joel Salinas, clinical assistant professor of neurology at NYU Langone Health and chief medical officer at Isaac Health, spoke with Cheddar News anchor Shannon LaNier about Alzheimer's disease and struggles to find an effective treatment.
Novo Nordisk Slashes Insulin Drug Prices By 75%
Novo Nordisk is lowering the list prices of its Insulin drug, following Eli Lilly's lead earlier this month.
Lunchables To Join National School Lunch Program
Kraft Heinz said its Lunchables product will be part of the school lunch program next year.
Veterans Health Administration to Foot the Bill for $26K Experimental Alzheimer's Drug
The Veterans Health Administration announced it will shell out more than $26,000 annually for each veteran on experimental Alzheimer's drug Leqembi.
Veterans Health Administration to Cover Alzheimer’s Drug
The Veterans Health Administration announced it would cover Leqembi, an Alzheimer's drug that's been deemed too expensive.
Study Finds Vaccine Efficacy Blunted by Lack of Sleep — in Men
A meta-analysis published in Current Biology suggests men who get fewer than six hours of sleep a night leading up to a vaccination had a weaker antibody response compared to those who got more sleep.
Google Says New Search Feature Will Increase Access to Low-Cost Health Care
At its annual health event on Tuesday, Google announced a series of changes to its search tool that it said will make it easier to access information about affordable health care services.
